Trade Amarin Corporation plc - AMRN CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.2030 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023346% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001124% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 11.0285 |
| Open | 10.6485 |
| 1-Year Change | 1114.06% |
| Day's Range | 10.2185 - 10.7685 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Apr 25, 2025 | 10.3585 | -0.2900 | -2.72% | 10.6485 | 10.8085 | 10.2185 |
| Apr 24, 2025 | 11.0285 | 0.9200 | 9.10% | 10.1085 | 11.1385 | 10.1085 |
| Apr 23, 2025 | 10.2885 | -0.4200 | -3.92% | 10.7085 | 10.7085 | 9.8885 |
| Apr 22, 2025 | 10.3985 | 0.8100 | 8.45% | 9.5885 | 10.6485 | 9.5485 |
| Apr 21, 2025 | 9.3985 | 0.4400 | 4.91% | 8.9585 | 9.5685 | 8.7485 |
| Apr 17, 2025 | 9.0485 | 0.0300 | 0.33% | 9.0185 | 9.2085 | 8.6985 |
| Apr 16, 2025 | 9.2085 | -0.4400 | -4.56% | 9.6485 | 9.7485 | 8.9985 |
| Apr 15, 2025 | 9.6285 | 0.2800 | 3.00% | 9.3485 | 9.9885 | 9.3485 |
| Apr 14, 2025 | 9.3785 | 0.3300 | 3.65% | 9.0485 | 9.4185 | 8.2385 |
| Apr 11, 2025 | 8.9985 | 0.0085 | 0.09% | 8.9900 | 9.9885 | 8.6985 |
| Apr 10, 2025 | 8.9900 | 0.0200 | 0.22% | 8.9700 | 9.2320 | 8.5200 |
| Apr 9, 2025 | 8.9700 | 1.0000 | 12.55% | 7.9700 | 9.1940 | 7.7980 |
| Apr 8, 2025 | 8.3760 | 0.2380 | 2.92% | 8.1380 | 9.1180 | 7.7600 |
| Apr 7, 2025 | 8.1860 | 0.2480 | 3.12% | 7.9380 | 8.5560 | 7.3760 |
| Apr 4, 2025 | 7.9300 | -0.3880 | -4.66% | 8.3180 | 8.3240 | 7.6980 |
| Apr 3, 2025 | 8.3620 | 0.0920 | 1.11% | 8.2700 | 8.9420 | 8.2000 |
| Apr 2, 2025 | 8.5700 | -0.0400 | -0.46% | 8.6100 | 8.8920 | 8.3140 |
| Apr 1, 2025 | 8.6420 | -0.2340 | -2.64% | 8.8760 | 9.1700 | 8.5700 |
| Mar 31, 2025 | 8.9100 | 0.3940 | 4.63% | 8.5160 | 8.9360 | 8.3720 |
| Mar 28, 2025 | 8.7040 | -0.2660 | -2.97% | 8.9700 | 9.1240 | 8.4200 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Amarin Corporation plc Company profile
Amarin Corporation (AMRN) is a clinical-stage biopharmaceutical company focused on the commercialisation and improvement of therapeutics to cure and deal with cardiovascular diseases.
Established in 1989, Amarin is headquartered in Dublin, Ireland, and operates in several European countries, the United States, Canada, Lebanon and the United Arab Emirates.
The company’s lead commercial product VASCEPA (icosapent ethyl) is a prescription-only omega-3 fatty acid product. Taken as an adjunct to diet, it reduces triglyceride levels in adult patients suffering from severe hypertriglyceridemia. The drug helps to address cardiovascular risk for millions of patients.
VASCEPA was launched in the United States in 2013, but gained wider recognition in 2019 as the US Food and Drug Administration (FDA) approved Amarin for a broader indication for cardiovascular risk reduction in studied high-risk patients. It has also got approval from the European Commission to reduce the risks for cardiac patients.
Amarin still prices VASCEPA at a considerably lower level than other new drugs of its category.
Formerly known as Ethical Holdings, the company changed its name to Amarin Corporation in 1999. The company went public in July 2019. It trades on the Nasdaq under the ticker ‘AMRN’.
| Industry: | Bio Therapeutic Drugs |
First Floor, Block 3, The Oval,
Shelbourne Road, Ballsbridge
DUBLIN
IE
News
ECB interest-rate forecasts – Projections for the next five years
The European Central Bank (ECB) plays a pivotal role in the economic stability of the eurozone, meaning ECB interest-rate forecasts are key to understanding how financial and economic scenarios might evolve.
14:37, 10 April 2025
BlackRock shareholders: Who owns the most BLK stock?
BlackRock is the leading asset manager in the world – but who are its biggest shareholders? Read on to find out.
13:46, 9 April 2025
Bitcoin price predictions 2025–2050: third-party price target
We examine bitcoin price predictions for 2025 and beyond, with insights from third-party analysts and market experts.
10:28, 9 April 2025
Tesla (TSLA) stock forecast 2025 and beyond: third-party Tesla price target
Where will Tesla’s stock be in five years? Can the EV company keep its crown?
08:19, 9 April 2025
JasmyCoin price predictions 2025-2030: Third-party price target
How might JASMY behave in the future?
16:13, 8 April 2025
Australian interest-rate projections: where will rates be in 5 years?
As one of the most closely watched economic indicators, Australian interest-rate projections offer valuable insight into the future of the country’s economy.
21:37, 7 April 2025
Copper price forecast: third-party price target
What’s next for the copper market? Read on for the latest analysis of the commodity's price and potential outlook.
17:31, 14 March 2025People also watch
Still looking for a broker you can trust?
Join the 720,000+ traders worldwide that chose to trade with Capital.com